Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2012 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Other Working Capital Changes of -$202821.0 for Q1 2026, down 16.58% sequentially from -$173983.0 in Q4 2025, and up 31.0% YoY from -$154825.6 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Other Working Capital Changes for 15 years, with the latest figure at -$202821.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 31.0% year-over-year to -$202821.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$744979.0 (down 155.87% YoY) and the FY2025 annual result came in at -$836100.0, down 146.86% from the prior year.
- Other Working Capital Changes fell to -$202821.0 in Q1 2026 per CPIX's latest filing, from -$173983.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.7 million in Q4 2022 and troughed at -$3.1 million in Q3 2022.
- A 5-year average of -$64492.9 and a median of -$239862.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 822.73% in 2022, down 482.06% in 2022.
- Over 5 years, Other Working Capital Changes stood at $2.9 million in 2022, then plunged by 127.8% to -$804124.0 in 2023, then surged by 366.99% to $2.1 million in 2024, then sank by 108.1% to -$173983.0 in 2025, then fell by 16.58% to -$202821.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$202821.0, -$173983.0, and -$221675.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Cumberland Pharmaceuticals | 117.01 Mn | 113.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 427,093.00 |
| Jun 30, 2026 | 427,093.00 |
| Jun 30, 2026 | 427,093.00 |
| Mar 31, 2026 | -384,152.00 |
| Mar 31, 2026 | -384,152.00 |
| Mar 31, 2026 | -384,152.00 |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | -178,936.00 |
| Sep 30, 2025 | -178,936.00 |
| Sep 30, 2025 | -178,936.00 |
| Jun 30, 2025 | -579,652.00 |
| Jun 30, 2025 | -579,652.00 |
| Jun 30, 2025 | -579,652.00 |
| Mar 31, 2025 | -60,371.00 |
| Mar 31, 2025 | -60,371.00 |
| Mar 31, 2025 | -60,371.00 |
| Dec 31, 2024 | 833,606.00 |
| Dec 31, 2024 | 833,606.00 |